Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT02233712
Status:
COMPLETED
Last Update Posted:
2014-09-08
First Post:
2014-08-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Open-label, Dose-finding Study to Determine Antibody Response to G17DT Treatment in Patients With Gastric Cancer.
Sponsor:
Cancer Advances Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-08
Start Date Type:
None
Primary Completion Date:
2000-03
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2014-08-27
First Submit QC Date:
None
Study First Post Date:
2014-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-09-05
Last Update Post Date:
2014-09-08
Last Update Post Date Type:
ESTIMATED